| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/08/2013 | CN103086946A Method for purifying ropinirole hydrochloride |
| 05/08/2013 | CN103086945A Synthetic process of important pharmaceutical chemical intermediate tryptamine |
| 05/08/2013 | CN103086944A Process for making n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide and starting materials therefor |
| 05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
| 05/08/2013 | CN103086942A Heterocyclic compound and organic light-emitting diode comprising the same |
| 05/08/2013 | CN102382038B Preparation method for synthesizing carbazoles alkaloid Siamenol |
| 05/08/2013 | CN102229558B New silodosin crystal form delta, preparation method thereof and pharmaceutical composition containing the same |
| 05/08/2013 | CN101774879B Method for simultaneously extracting high-purity beta-methylnaphthalene and indole from coal tar |
| 05/07/2013 | US8436104 Polymer |
| 05/07/2013 | US8436040 Method of treating conditions involving PPAR-receptors with indole compounds |
| 05/07/2013 | CA2538864C Thalidomide analogs as tnf-alpha modulators |
| 05/02/2013 | WO2013063492A1 Novel compositions and methods for treating cancer |
| 05/02/2013 | WO2013063468A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | WO2013063462A2 Method of treating hcv infection with a small molecule chk2 inhibitor |
| 05/02/2013 | WO2013062344A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
| 05/02/2013 | WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element |
| 05/02/2013 | WO2013062043A1 4-aminocarbazole compound and use of same |
| 05/02/2013 | WO2013061669A1 Benzohydrazide derivative for inducing g2/m phase arrest and cell death |
| 05/02/2013 | WO2013060818A1 Novel process |
| 05/02/2013 | WO2013032304A3 Organic electronic device and method for manufacturing same |
| 05/02/2013 | WO2013032303A3 Organic electronic device |
| 05/02/2013 | US20130109866 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | US20130109734 Gpr120 receptor agonists and uses thereof |
| 05/02/2013 | US20130109721 FAAH Inhibitors |
| 05/02/2013 | US20130109686 Isoindolone m1 receptor positive allosteric modulators |
| 05/02/2013 | US20130109672 Activators of human pyruvate kinase |
| 05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
| 05/02/2013 | US20130108560 Chemical Treatments for the Disruption of Dental Plaque Biofilms and Related Methods |
| 05/02/2013 | CA2853729A1 Novel compositions and methods for treating cancer |
| 05/02/2013 | CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | CA2846066A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof |
| 05/01/2013 | EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator |
| 05/01/2013 | EP2584903A1 Novel heterocyclic compounds as erk inhibitors |
| 05/01/2013 | CN103081155A Light-emitting element |
| 05/01/2013 | CN103080085A Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1H-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid |
| 05/01/2013 | CN103073481A Preparation method for 4-azaspiro [2.4] heptane hydrochloride |
| 05/01/2013 | CN103073480A Preparation method for 2-(t-butyloxycarbonyl) octahydrocyclopenta [c] pyrrole-5-carboxylic acid |
| 05/01/2013 | CN103073393A Method for preparing hydroxy-substituted polycyclic aromatic compound |
| 05/01/2013 | CN103073373A Alpha-hydroxymethyl-alpha-aryl-alpha-amino acid derivatives and preparation method thereof |
| 05/01/2013 | CN102397275B Aromatization enzyme inhibitor |
| 05/01/2013 | CN102309984B Phosphoric acid amide bifunctional catalyst and synthetic method thereof |
| 05/01/2013 | CN101898995B Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 05/01/2013 | CN101558038B Curcumin derivative |
| 05/01/2013 | CN101528223B New small molecule inhibitors of MDM2 and the uses thereof |
| 05/01/2013 | CN101056852B Iodine-phenyl-substituted cyclic cetoenols |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431720 Indolesulfonyl protecting groups for protection of guanidino and amino groups |
| 04/30/2013 | US8431719 Heteroleptic pyrrolecarbaldimine precursors |
| 04/30/2013 | US8431708 Fluorescent carbazole compounds for cancer diagnosis |
| 04/30/2013 | US8431602 Beta-amino acid derivatives for treatment of diabetes |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431407 Temperature/irradiation/polymerization indicators |
| 04/30/2013 | US8431252 Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative |
| 04/25/2013 | WO2013059245A1 Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| 04/25/2013 | WO2013058098A1 Organic electroluminescent element |
| 04/25/2013 | WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/25/2013 | WO2013057258A1 Processes for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide and of its precursors |
| 04/25/2013 | WO2013056842A1 Method for preparing silodosin |
| 04/25/2013 | WO2013056776A1 Materials for organic electroluminescent devices |
| 04/25/2013 | US20130102774 Thionation process and a thionating agent |
| 04/25/2013 | US20130102756 Novel curing agents |
| 04/25/2013 | US20130102640 Method for the preparation of cis-1,2-diols in the kilogram scale |
| 04/25/2013 | US20130102626 Targeted nitroxide agents |
| 04/25/2013 | US20130102609 Biaryl oxyacetic acid compounds |
| 04/25/2013 | US20130102604 Novel cyclopropane indolinone derivatives |
| 04/25/2013 | DE102011085136A1 Use of new or known guanidine compound or a mixture comprising of two or more guanidine compounds e.g. as flavoring agent for creating, mediating, modifying and/or amplifying a salty flavor impression of sodium chloride |
| 04/25/2013 | CA2852797A1 Processes for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide and of its precursors |
| 04/25/2013 | CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| 04/24/2013 | EP2583964A1 Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid |
| 04/24/2013 | EP2583956A2 A method of preparation of polycyclic, fused aromatic and heteroaromatic hydrocarbons and intermediates |
| 04/24/2013 | EP2583326A1 Use of substituted perylenes in organic solar cells |
| 04/24/2013 | EP2582668A1 Carboline carboxamide compounds useful as kinase inhibitors |
| 04/24/2013 | EP2582667A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators |
| 04/24/2013 | EP2582666A2 Aryl substituted indoles and their use as blockers of sodium channels |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN103068799A Benzamide derivatives and their use as hsp90 inhibtors |
| 04/24/2013 | CN103058913A Method for synthesizing 5-isoindolone chloride |
| 04/24/2013 | CN103058912A Preparation method of 3-(4-chlorobutyl)indole-5-formonitrile |
| 04/24/2013 | CN103058867A Fatty acid analogues, i.e. dha derivatives for uses as a medicament |
| 04/24/2013 | CN102167715B Eutectic preparation method of sodium-glucose cotransporter 2 bulk pharmaceutical chemicals |
| 04/24/2013 | CN101906007B Preparation method of organic azide |
| 04/24/2013 | CN101626835B Immobilized cyclic imide catalyst and process for oxidation of organic compounds with the same |
| 04/24/2013 | CN101550085B Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/24/2013 | CN101528689B Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| 04/23/2013 | US8426636 Sterically bulky stabilizers |
| 04/23/2013 | US8426618 Luminescence quenching compounds |
| 04/23/2013 | US8426612 Synthesis of 3-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-5[2-(phenylsulfonyl)ethyl]-1H-indole |
| 04/23/2013 | US8426611 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 04/23/2013 | US8426609 Polymers functionalized with imide compounds containing a protected amino group |
| 04/23/2013 | US8426541 Synthetic mycotoxin adsorbents and methods of making and utilizing the same |
| 04/23/2013 | US8426495 Radiation-curable ink composition for inkjet recording, inkjet recording method, and printed matter |
| 04/23/2013 | US8426422 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/23/2013 | CA2594280C 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists |
| 04/18/2013 | US20130096317 Reduction of aldehydes and ketones to alcohols |
| 04/18/2013 | US20130096303 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 04/18/2013 | US20130096277 Processes and intermediates |
| 04/18/2013 | US20130096175 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms |
| 04/17/2013 | EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/17/2013 | EP2580193A1 Benzamide derivatives and their use as hsp90 inhibtors |
| 04/17/2013 | CN1968925B Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |